01
Carbon input
Residual industrial carbon and renewable carbon feedstock are inputs in the company-described approach to biochemical manufacture.
THE PLATFORM
A new purpose for carbon.
From residual industrial carbon to designed biochemical outputs: explore the concepts behind Lypo’s platform approach.
Conceptual visualization
01 / 04
Carbon input
Residual industrial carbon and renewable carbon feedstock are inputs in the company-described approach to biochemical manufacture.
02
AI-powered protein design
AI-powered protein design and engineering are part of the approach to exploring enzyme designs.
03
High-throughput variant screening
High-throughput screening of enzyme variants helps identify candidates for performance targets. Screening capacity and assay results have not yet been published.
04
Cosmetic ingredient targets
The current target application is high-performance biodegradable cosmetic ingredients with programmable functional properties, in development rather than commercially available.
Design, screen, develop.
Metabolic engineering, fermentation and bioprocess optimisation connect biological design with the ambition of sustainable manufacture. The platform is in development; industrial scale and performance remain to be demonstrated.
The approach, in context.
What is Lypo developing?
A platform for bespoke biochemicals from renewable and waste-derived carbon, combining protein design, enzyme screening and bioprocess development.
Are products currently available?
Cosmetic ingredients are target applications in development, not a commercially available product catalogue.
What is the therapeutic ambition?
Advanced therapeutics are a long-term platform goal, not a current clinical pipeline or evidence of efficacy.
LET’S CONNECT
Let’s explore the possibilities.
Connect with Lypo to discuss its platform and potential collaboration.